(VIANEWS) - Harmony Biosciences Holdings (HRMY), Everest Re Group, Ltd. (RE), Credicorp Ltd. (BAP) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Harmony Biosciences Holdings (HRMY)
36.2% sales growth and 31.15% return on equity
Harmony Biosciences Holdings, Inc. is a pharmaceutical company at the commercial stage that develops and markets therapies for rare neurological conditions. WAKIX, the company's drug product is used to treat excessive sleepiness among adults with narcolepsy. In February 2020, Harmony Biosciences II, Inc. was the company's name. The company changed its name from Harmony Biosciences II, Inc. to Harmony Biosciences Holdings, Inc. Harmony Biosciences Holdings, Inc. is an organization that was founded in 2017. Its headquarters are in Plymouth Meeting, Pennsylvania.
Harmony Biosciences Holdings's sales growth this year is expected to be 40.8% and 37.2% for next year.
Year-on-year quarterly revenue growth grew by 45%, now sitting on 364.29M for the twelve trailing months.
Volume
Today's last reported volume for Harmony Biosciences Holdings is 470383 which is 15.3% below its average volume of 555409.
Harmony Biosciences Holdings's sales growth for the next quarter is 36.2%. The company's growth estimates for the current quarter and the next is 217.6% and 36.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.15%.
Volatility
Harmony Biosciences Holdings's last day, last week, and last month's current intraday variation average was 1.60%, 2.75%, and 2.93%, respectively.
Harmony Biosciences Holdings's highest amplitude of average volatility was 3.27% (day), 4.50% (last week), and 4.97% (last month), respectively.
Harmony Biosciences Holdings's Stock Yearly Top and Bottom Value
Harmony Biosciences Holdings's stock is valued at $47.08 at 06:22 EST, way below its 52-week high of $57.13 and way above its 52-week low of $31.54.
Harmony Biosciences Holdings's Moving Average
Harmony Biosciences Holdings's worth is below its 50-day moving average of $50.57 and higher than its 200-day moving average of $43.90.2. Everest Re Group, Ltd. (RE)
18.5% sales growth and 8.07% return on equity
Through its subsidiaries, Everest Re Group, Ltd. provides insurance products and reinsurance in the United States, Bermuda, as well as internationally. It operates in four areas: U.S. Insurance, International, Bermuda and Reinsurance are the four segments of the company. U.S. The U.S. Reinsurance Segment writes property and casualty insurance; as well as specialty lines, such as marine, aviation and surety as well as accident and health insurance directly through ceding businesses in the United States. International writes casualty and property reinsurance in Canada and other countries such as Brazil, New Jersey, Singapore, Brazil and Miami. Reinsurance, insurance and other services to Bermuda's property and casualty market markets are provided by the Bermuda segment. This includes direct contact with Bermuda ceding firms and brokers as well as reinsurance for European and UK markets. The Insurance segment offers property and casualty insurance products through direct sales, general agents, wholesalers, retailers, surplus lines brokers and directly to customers in the United States. It also offers property and casualty insurance and coverages such as directors' and officer's liability, errors and omissions liability and medical malpractice. Everest Re Group, Ltd., was established in 1973. It is located in Hamilton, Bermuda.
Everest Re Group, Ltd.'s sales growth this year is expected to be 23.2% and 8.4% for next year.
Year-on-year quarterly revenue growth declined by 5.3%, now sitting on 11.86B for the twelve trailing months.
Volume
Today's last reported volume for Everest Re Group, Ltd. is 118630 which is 48.58% below its average volume of 230722.
Everest Re Group, Ltd.'s sales growth is a negative 0% for the present quarter and 18.5% for the next. The company's growth estimates for the present quarter and the next is 392.4% and 15.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.07%.
Volatility
Everest Re Group, Ltd.'s last day, last week, and last month's current intraday variation average was 1.43%, 1.23%, and 1.25%, respectively.
Everest Re Group, Ltd.'s highest amplitude of average volatility was 1.73% (day), 1.45% (last week), and 1.53% (last month), respectively.
Everest Re Group, Ltd.'s Stock Yearly Top and Bottom Value
Everest Re Group, Ltd.'s stock is valued at $272.92 at 06:22 EST, way under its 52-week high of $308.20 and higher than its 52-week low of $248.63.
Everest Re Group, Ltd.'s Moving Average
Everest Re Group, Ltd.'s worth is higher than its 50-day moving average of $271.20 and under its 200-day moving average of $279.31.3. Credicorp Ltd. (BAP)
15.7% sales growth and 15.87% return on equity
Credicorp Ltd. is a holding company for financial services. It provides a variety of financial and insurance products, as well as financial and other services, both in Peru and abroad. Universal Banking, the company's segment, offers current and deposits as well as various financial instruments and credits to legal entities and individuals. The Insurance and Pensions segment provides insurance policies for commercial property, transport, vessels, vehicles, life and health. It also manages private pension funds and offers management services. Microfinance, a subsidiary of the company, manages microenterprises' current and future accounts, loans, credit, deposits and current accounts. The company's Investment Banking and Wealth Management section offers services to institutions, foundations, corporations and governments. It structures and places issues on the primary and secondary markets, and executes and negotiates operations in the second market. Additionally, it manages mutual funds and securitizations for corporate clients. It was established in Lima in Peru in 1889.
Credicorp Ltd.'s sales growth this year is expected to be 76.3% and a negative 27.9% for next year.
Year-on-year quarterly revenue growth grew by 34%, now sitting on 13.96B for the twelve trailing months.
Volume
Today's last reported volume for Credicorp Ltd. is 204734 which is 39.11% below its average volume of 336246.
Credicorp Ltd.'s sales growth is a negative 0% for the ongoing quarter and 15.7% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 0% and 63.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.87%.
Volatility
Credicorp Ltd.'s last day, last week, and last month's current intraday variation average was 0.20%, 1.01%, and 1.45%, respectively.
Credicorp Ltd.'s highest amplitude of average volatility was 1.82% (day), 2.03% (last week), and 2.62% (last month), respectively.
Credicorp Ltd.'s Stock Yearly Top and Bottom Value
Credicorp Ltd.'s stock is valued at $130.35 at 06:22 EST, way under its 52-week high of $182.11 and way higher than its 52-week low of $101.66.
Credicorp Ltd.'s Moving Average
Credicorp Ltd.'s value is above its 50-day moving average of $127.40 and below its 200-day moving average of $136.44.4. Ingredion Incorporated (INGR)
12.4% sales growth and 15.13% return on equity
Ingredion Incorporated and its affiliates produce and sell sweeteners and starches for various industries. The company operates in four regions: North America, South America, Asia Pacific, Europe, Middle East and Africa. It offers sweeteners such as glucose syrups and high-maltose syrups as well as caramel colors and maltodextrins. The company also offers animal feed products, edible corn oil, refined corn oil for packers of cooking oils and producers of shortenings, mayonnaise and margarine; as well as corn gluten feed that is used to provide protein feed to chickens and pet food. Products of the company are made mainly from corn, tapioca and potato starch, as well as other starch-based material, like rice, potato and tapioca. The company serves the food, beverage and paper, corrugating, pharmaceutical, textile and personal care markets as well as the animal feed market. Ingredion Incorporated was founded in June 2012 as Corn Products International, Inc. Ingredion Incorporated is an Illinois-based company that was established in 1906.
Ingredion Incorporated's sales growth this year is anticipated to be 15.3% and 4.9% for next year.
Year-on-year quarterly revenue growth grew by 16%, now sitting on 7.45B for the twelve trailing months.
Volume
Today's last reported volume for Ingredion Incorporated is 370638 which is 13.97% above its average volume of 325191.
Ingredion Incorporated's sales growth for the next quarter is 12.4%. The company's growth estimates for the ongoing quarter and the next is a negative 2.4% and 30.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.13%.
Volatility
Ingredion Incorporated's last day, last week, and last month's current intraday variation average was 1.65%, 1.43%, and 1.02%, respectively.
Ingredion Incorporated's highest amplitude of average volatility was 1.93% (day), 1.73% (last week), and 1.88% (last month), respectively.
Ingredion Incorporated's Stock Yearly Top and Bottom Value
Ingredion Incorporated's stock is valued at $89.57 at 06:22 EST, way below its 52-week high of $101.89 and way higher than its 52-week low of $81.25.
Ingredion Incorporated's Moving Average
Ingredion Incorporated's worth is higher than its 50-day moving average of $89.38 and under its 200-day moving average of $91.26.5. M/I Homes (MHO)
5.7% sales growth and 26.37% return on equity
M/I Homes, Inc., along with its affiliates, is a single-family home builder in Ohio, Indiana, Illinois, Michigan, Minnesota, North Carolina, Florida, Texas, and Texas, respectively. It operates in three segments: Northern Homebuilding and Southern Homebuilding. Financial Services is also part of the company's operations. The company designs, builds, markets and sells attached townhomes and single-family homes to first-time buyers, luxury buyers, empty nesters, young professionals, and millennials. It also buys undeveloped land for development into single-family home construction lots, and for sale to other buyers. It also originates and offers mortgages. The company is also a title agent, providing title insurance policies and examinations to its customers. M/I Schottenstein Homes, Inc. was the company's previous name. In January 2004, M/I Homes, Inc. became M/I Homes, Inc. M/I Homes, Inc. was established in 1976. It is located in Columbus, Ohio.
M/I Homes's sales growth this year is anticipated to be 8.4% and 3.8% for next year.
Year-on-year quarterly revenue growth grew by 8.3%, now sitting on 3.86B for the twelve trailing months.
Volume
Today's last reported volume for M/I Homes is 222635 which is 15.69% below its average volume of 264083.
M/I Homes's sales growth for the next quarter is 5.7%. The company's growth estimates for the present quarter and the next is 33.7% and 16.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.37%.
Volatility
M/I Homes's last day, last week, and last month's current intraday variation average was 3.28%, 2.19%, and 2.12%, respectively.
M/I Homes's highest amplitude of average volatility was 4.74% (day), 3.80% (last week), and 3.44% (last month), respectively.
M/I Homes's Stock Yearly Top and Bottom Value
M/I Homes's stock is valued at $44.78 at 06:22 EST, way under its 52-week high of $69.22 and way above its 52-week low of $34.33.